Three insiders sell Opus Genetics, Inc. shares, $278,926 in total
Open-market sales between Oct 23 and Nov 3, none marked as part of a 10b5-1 plan.
Three insiders at Opus Genetics, Inc. (IRD) sold shares on the open market between Oct 23 and Nov 3, a combined $278,926, according to Form 4 filings with the SEC.
The largest sale came from Benjamin R Yerxa, a president, who sold 33,189 shares for $117,365. The table below lists who sold, when, and at what price.
George Magrath (CEO) is the latest to report, in a filing on Nov 5. Three or more insiders selling within 14 days is what Insider Stock Trader labels a cluster sell.
The numbers below are taken from the Form 4 as filed with the SEC.
| Insider | Role | Trade date | Shares | Avg. price | Value | Filing |
|---|---|---|---|---|---|---|
| George Magrath | CEO | Oct 23 | 9,591 | $3.59 | $34,384 | App · SEC |
| Benjamin R Yerxa | President | Oct 23 | 33,189 | $3.54 | $117,365 | App · SEC |
| Joseph K Schachle | COO | Oct 23 | 4,767 | $3.57 | $16,994 | App · SEC |
| George Magrath | CEO | Nov 3 | 28,258 | $3.90 | $110,184 | App · SEC |
| Total | $278,926 | |||||
See more details on these IRD insider trades
Each row of the table links to its Form 4 on SEC.gov.
See where several insiders traded together · Browse the latest insider selling
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.